Rapid Test for Cancer Developed by Researchers
The team at the University of Queensland in Australia created the test after discovering that cancer forms a unique DNA structure when placed in water, CNN reported. (Source: WebMD Health)
Source: WebMD Health - December 5, 2018 Category: Consumer Health News Source Type: news

Cancer-VTE Trial Falls Short
(MedPage Today) -- High dropout rate undermines rivaroxaban prophylaxis trial (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - December 5, 2018 Category: Cardiology Source Type: news

ASH: Rivaroxaban Prevents Blood Clots in At - Risk Cancer Patients
Risk for patients in rivaroxaban group reduced during the on - treatment period (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - December 5, 2018 Category: Cancer & Oncology Tags: Cardiology, Oncology, Pharmacy, Conference News, Source Type: news

Lung cancer symptoms: Eight signs of the disease that are often ignored
LUNG cancer symptoms can easily mistaken for less serious health conditions, which is why the disease often isn ’t diagnosed until it’s reached later stages. Here are seven signs often overlooked or ignored. (Source: Daily Express - Health)
Source: Daily Express - Health - December 5, 2018 Category: Consumer Health News Source Type: news

Medical News Today: Universal 10-minute cancer test in sight
Cancer cells have a unique pattern of chemical tags on their DNA, which differs from that of healthy cells and could serve as the basis for a universal test. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - December 5, 2018 Category: Consumer Health News Tags: Cancer / Oncology Source Type: news

From Patent to Patient: our report analysing access to innovative cancer drugs
This report highlights the progress that is being made with discovering new cancer medicines and draws attention to key challenges that will need to be overcome to ensure more patients can benefit from these advances. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - December 5, 2018 Category: Consumer Health News Source Type: news

Too Much Sleep Linked To Greater Risk Of Disease & Death, Study Finds
(CNN) — The recommended amount of sleep for adults is six to eight hours a night. Sleeping more than those hours is associated with an increased risk of death and cardiovascular diseases, says a global study published Wednesday in the European Heart Journal. Looking at data from 21 countries, across seven regions, the research team found that people sleeping more than the recommended upper limit of eight hours increased their risk of major cardiovascular events, like stroke or heart failure, as well as death by up to 41%. But a possible reason for this could be that people have underlying conditions causing them to s...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - December 5, 2018 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health News Local TV Sleep Source Type: news

The Future Of Cancer Care: A 50 Minute Discussion At Forbes
The future of cancer therapy, an analysis of how Immunotherapy has improved oncology outcomes for patients. This year's Forbes Summit highlighted both the difficulties, advancements and needs of the cancer care community in order to find the " cure " for cancer. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - December 5, 2018 Category: Pharmaceuticals Authors: Steve Brozak, Contributor Tags: NYSE:MRK NASDAQ:LOXO NASDAQ:ALLO Source Type: news

Cancer services profiles: 2018 annual update
This new profile tool brings together a selection of mortality indicators from other PHE data tools, making it easier to assess outcomes across a range of causes of death. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - December 5, 2018 Category: Consumer Health News Source Type: news

Worldwide hunt for rare blood to help Miami girl fight cancer
The 2-year-old with some of the rarest blood in the world who is also battling a very aggressive form of cancer (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - December 5, 2018 Category: Consumer Health News Source Type: news

Can Anthracyclines be Excluded From Neoadjuvant HER2+ Breast Cancer Tx?
A comparison of chemotherapy regimens plus anti-HER2 therapy in the neoadjuvant setting tested whether the addition of anthracyclines is necessary for patients with HER2-positive breast cancer. (Source: CancerNetwork)
Source: CancerNetwork - December 5, 2018 Category: Cancer & Oncology Authors: Dave Levitan Source Type: news

Varian Halcyon Treatment System Receives China NMPA Approval
To view this release online and get more information about Varian visit: www.varian.com/newsroom PALO ALTO, Calif., Nov. 28, 2018 /PRNewswire/ -- Varian (NYSE: VAR) today announced its Halcyon™ system has been approved by the China National Medical Product Administration (NMPA), which allows the company to market this new cancer treatment system in China.  This approval further expands the global availability of Halcyon and access to high-quality, cost-effective cancer...This story is related to the following:Radiotherapy Systems (Source: Industrial Newsroom - Health, Medical and Dental Supplies)
Source: Industrial Newsroom - Health, Medical and Dental Supplies - December 5, 2018 Category: Medical Devices Source Type: news

Drug Halves Recurrence for Common Breast Cancer
All of the women in the new trial had undergone a standard treatment scenario. First, they received traditional chemotherapy and the drug Herceptin (trastuzumab) -- an antibody that targets HER2-positive cancer cells. Then they had surgery to remove any remaining cancer. (Source: WebMD Health)
Source: WebMD Health - December 5, 2018 Category: Consumer Health News Source Type: news

Too Much Time in the Sun? Skin Patch Might Tell
WEDNESDAY, Dec. 5, 2018 -- A new mint-sized, battery-free patch that alerts wearers to potentially harmful sunlight exposure in real time might become a powerful weapon in preventing skin cancer. Powered by the sun while designed to measure its... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - December 5, 2018 Category: General Medicine Source Type: news

Roche ’s Kadcyla cut the risk of disease recurring by half compared to Herceptin in people with HER2-positive early breast cancer with residual disease after neoadjuvant treatment
Roche today announced that the phase III KATHERINE study met its primary endpoint, showing Kadcyla ® (trastuzumab emtansine) as a single agent significantly reduced the risk of disease recurrence or death (invasive disease-free survival; iDFS) by 50% (HR=0.50, 95% CI 0.39-0.64, p (Source: Roche Investor Update)
Source: Roche Investor Update - December 5, 2018 Category: Pharmaceuticals Source Type: news

Roche ’s Kadcyla cut the risk of disease recurring by half compared to Herceptin in people with HER2-positive early breast cancer with residual disease after neoadjuvant treatment
Roche today announced that the phase III KATHERINE study met its primary endpoint, showing Kadcyla ® (trastuzumab emtansine) as a single agent significantly reduced the risk of disease recurrence or death (invasive disease-free survival; iDFS) by 50% (HR=0.50, 95% CI 0.39-0.64, p (Source: Roche Media News)
Source: Roche Media News - December 5, 2018 Category: Pharmaceuticals Source Type: news

ASH: Rivaroxaban Prevents Blood Clots in At-Risk Cancer Patients
WEDNESDAY, Dec. 5, 2018 -- Rivaroxaban can prevent venous thromboembolism (VTE) in cancer patients at increased risk, according to a study presented at the annual meeting of the American Society of Hematology, held from Dec. 1 to 4 in San... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 5, 2018 Category: Pharmaceuticals Source Type: news

10-minute cancer test detects cancer anywhere in the body, new study says
Researchers in Australia have developed a 10-minute test that can detect the presence of cancer cells anywhere in the human body, according to a newly published study. (Source: CNN.com - Health)
Source: CNN.com - Health - December 5, 2018 Category: Consumer Health News Source Type: news

How we improved end-of-life care in our practice
Dr Victoria Middleton explains how her practice has increased the number of patients on its palliative care register, reduced avoidable hospital admissions and increased the number of people able to die at home by a third. (Source: GP Online Education)
Source: GP Online Education - December 5, 2018 Category: Primary Care Tags: 12 Care of People with Cancer and Palliative Care Source Type: news

Cochrane Library Special Collection: Diagnosing skin cancer
ThisSpecial Collection of Cochrane Systematic Reviews brings together a large body of research on the accuracy of tests used to diagnose skin cancer.The suite of eleven reviews was  led by Dr Jac Dinnes at the University of Birmingham and supported by theCochrane Skin Group and a team of over 30 researchers and expert advisors, funded by the  National Institute for Health Research (NIHR).   The reviews  summarise research evidence assessing the accuracy of different diagnostic tests to support clinical and policy related decision making in the diagnosis of all types of skin cancer. D...
Source: Cochrane News and Events - December 5, 2018 Category: Information Technology Authors: Katie Abbotts Source Type: news

Kadcyla Halves Tumor Recurrence for Women With a Common Breast Cancer
WEDNESDAY, Dec. 5, 2018 -- For certain women with early stage breast cancer, a newer drug that combines an antibody with chemotherapy may cut the risk of disease recurrence in half, a new trial finds. The study focused on nearly 1,500 women with... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - December 5, 2018 Category: General Medicine Source Type: news

Drug Halves Tumor Recurrence for Women With a Common Breast Cancer
WEDNESDAY, Dec. 5, 2018 -- For certain women with early stage breast cancer, a newer drug that combines an antibody with chemotherapy may cut the risk of disease recurrence in half, a new trial finds. The study focused on nearly 1,500 women with... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - December 5, 2018 Category: General Medicine Source Type: news

Zimbabwe: Treat Chronic Diseases for Free, Says Ruling Party
[The Herald] The Zanu-PF Mashonaland West province has resolved that chronic conditions such as cancer and diabetes should be treated free of charge. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - December 5, 2018 Category: African Health Source Type: news

10-minute cancer test could detect cancer anywhere in the body, new study says
Researchers in Australia have developed a 10-minute test that can detect the presence of cancer cells anywhere in the human body, according to a newly published study. (Source: CNN.com - Health)
Source: CNN.com - Health - December 5, 2018 Category: Consumer Health News Source Type: news

Roche's Tecentriq wins speedy U.S. FDA review for small cell lung cancer
Swiss group Roche Holding AG said on Wednesday its Tecentriq immunotherapy mixed with chemotherapy won priority review from the U.S. regulator for treating a type of lung cancer, a potential boost to the drug that has been trailing rivals' revenues. (Source: Reuters: Health)
Source: Reuters: Health - December 5, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Rapid Test for Cancer Developed by Researchers
Title: Rapid Test for Cancer Developed by ResearchersCategory: Health NewsCreated: 12/5/2018 12:00:00 AMLast Editorial Review: 12/5/2018 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - December 5, 2018 Category: Cancer & Oncology Source Type: news

Drug Halves Tumor Recurrence for Women With a Common Breast Cancer
Title: Drug Halves Tumor Recurrence for Women With a Common Breast CancerCategory: Health NewsCreated: 12/5/2018 12:00:00 AMLast Editorial Review: 12/5/2018 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - December 5, 2018 Category: Cancer & Oncology Source Type: news

Treatment of Breast Cancer by Stages
Title: Treatment of Breast Cancer by StagesCategory: Diseases and ConditionsCreated: 8/21/2015 12:00:00 AMLast Editorial Review: 12/5/2018 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - December 5, 2018 Category: Cancer & Oncology Source Type: news

Roche's Tecentriq wins speedy U.S. review in small cell lung cancer
Roche's Tecentriq immunotherapy with chemotherapy won priority review in the United States for the initial treatment of extensive-stage small cell lung cancer (SCLC), the company said, setting up possible approval by March 18. (Source: Reuters: Health)
Source: Reuters: Health - December 5, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Managing Afib in Cancer Patients Taking BTK Inhibitors
Cancer Network speaks with Dr. Leon Ptaszek about managing cancer patients who have atrial fibrillation and are being treated with BTK inhibitors. (Source: CancerNetwork)
Source: CancerNetwork - December 5, 2018 Category: Cancer & Oncology Authors: Leon M. Ptaszek, MD, PhD Source Type: news

FDA grants priority review to Roche ’s Tecentriq in combination with chemotherapy for the initial treatment of extensive-stage small cell lung cancer
Roche today announced that the US Food and Drug Administration (FDA) has accepted the company ’s supplemental Biologics License Application (sBLA) and granted Priority Review for Tecentriq® (atezolizumab), in combination with carboplatin and etoposide (chemotherapy), for the initial (first-line) treatment of people with extensive-stage small cell lung cancer (ES - SCLC). (Source: Roche Investor Update)
Source: Roche Investor Update - December 5, 2018 Category: Pharmaceuticals Source Type: news

FDA grants priority review to Roche ’s Tecentriq in combination with chemotherapy for the initial treatment of extensive-stage small cell lung cancer
Roche today announced that the US Food and Drug Administration (FDA) has accepted the company ’s supplemental Biologics License Application (sBLA) and granted Priority Review for Tecentriq® (atezolizumab), in combination with carboplatin and etoposide (chemotherapy), for the initial (first-line) treatment of people with extensive-stage small cell lung cancer (ES - SCLC). (Source: Roche Media News)
Source: Roche Media News - December 5, 2018 Category: Pharmaceuticals Source Type: news

Newly identified T cells could play a role in cancer and other diseases
(University of California - Los Angeles Health Sciences) Researchers from the UCLA Jonsson Comprehensive Cancer Center and the La Jolla Institute for Immunology have identified a new type of T cell called a phospholipid-reactive T cell that is able to recognize phospholipids, the molecules that help form cells' outer membranes.The scientists also discovered that phospholipids compete with glycolipids, another type of molecule that helps form cells' outer membranes, in a way that prevents glycolipids from readily reaching the surface of a cell. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 5, 2018 Category: Cancer & Oncology Source Type: news

Revolutionary technology pinpoints biopsies to detect prostate cancer
(University College London) Medical software developed at UCL that overlays tumour information from MRI scans onto ultrasound images can help guide surgeons conducting biopsies and improve prostate cancer detection. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 5, 2018 Category: Cancer & Oncology Source Type: news

Adjuvant chemo might not add benefit in breast cancer patients who have excellent response to neoadjuvant chemo
(American Association for Cancer Research) Pathological complete response (pCR) after neoadjuvant (presurgery) chemotherapy was associated with significantly lower recurrence risk and higher overall survival in breast cancer patients, and pCR after neoadjuvant chemotherapy had similar association with improved outcomes among those who received additional chemotherapy following surgery (adjuvant chemotherapy) versus those who did not, according to meta-analyses of data from 52 clinical trials, presented at the 2018 San Antonio Breast Cancer Symposium. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 5, 2018 Category: Cancer & Oncology Source Type: news

Women who miss cervical cancer screenings could be asked to take samples at home
(BMJ) Women who do not respond to invitations to attend cervical cancer screening could be sent kits and asked to take their own vaginal samples at home so that samples can be sent to a laboratory for testing, suggests a study published in The BMJ today. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 5, 2018 Category: Cancer & Oncology Source Type: news

World's smallest wearable device warns of UV exposure, enables precision phototherapy
(Northwestern University) The world's smallest wearable, battery-free and virtually indestructible device has been developed to measure exposure to light across multiple wavelengths, from the ultra violet to visible and even infrared parts of the solar spectrum. Smaller than an M&M, the device can optimize treatment of neonatal jaundice, skin diseases, seasonal affective disorder and reduce risk of sunburns and skin cancer. It can record up to three separate wavelengths of light at one time. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 5, 2018 Category: Cancer & Oncology Source Type: news

Delaying adjuvant chemo associated with worse outcomes for patients with triple-negative breast cancer
(American Association for Cancer Research) Patients with triple-negative breast cancer who delayed starting adjuvant chemotherapy for more than 30 days after surgery were at significantly higher risk for disease recurrence and death compared with those who started the treatment in the first 30 days after surgery, according to a retrospective study presented at the 2018 San Antonio Breast Cancer Symposium. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 5, 2018 Category: Cancer & Oncology Source Type: news

Postdoc in UC Riverside School of Medicine receives prestigious NIH fellowship
(University of California - Riverside) Rebekah Charney, a postdoctoral researcher in the School of Medicine at the University of California, Riverside, has been awarded the prestigious Ruth L. Kirschstein National Research Service Award Individual Postdoctoral Fellowship by the National Institute of Dental and Craniofacial Research of the National Institutes of Health. The fellowship provides $177,000 to support Charney for three years to study the earliest events underlying the formation of neural crest cells. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 5, 2018 Category: Cancer & Oncology Source Type: news

A new therapeutic target for metastatic and resistant prostate cancers
(IDIBELL-Bellvitge Biomedical Research Institute) Researchers from IDIBELL and ICO showed that the most aggressive prostate tumors generate increasing levels of the NSD2 protein, which are related to tumor progression and therapeutic resistance.NSD2 inhibition could lead to the re-sensitization of those prostate tumors resistant to conventional antiandrogenic treatments.The study suggests an innovative, combined therapeutic approach that would include the administration of a NSD2 inhibitor drug together with conventional antiandrogenic drugs. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 5, 2018 Category: International Medicine & Public Health Source Type: news

DNA damage leads to genetic diseases and cancer
(AKSON Russian Science Communication Association) Scientists revealed how DNA damage influences mutations. Turned out that its contribution to mutagenesis was underestimated and many of the inheritance mutations are caused not by errors in DNA doubling, but by damage to this fragile molecule. The study was conducted by an international research group and published in Nature Genetics. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 5, 2018 Category: International Medicine & Public Health Source Type: news

Possible alterations in the DNA involved in cancer
(University of Seville) The study shows the role of the protein PIF1, capable of undoing different structures in these molecules. These molecules contain the instructions that allow cells to function correctly, so that when there is an alteration that is not repaired properly, mutations can occurred that can cause problems for the health of the body. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 5, 2018 Category: International Medicine & Public Health Source Type: news

Without Dna2, genes can jump into DNA breaks
(Baylor College of Medicine) When Dna2 is absent, small DNA fragments jump from all over the genome into chromosome breaks. This novel mechanism may explain similar events commonly seen in cancer or during antibody diversification. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 5, 2018 Category: International Medicine & Public Health Source Type: news

UC San Diego researchers develop sensors to detect and measure cancer's ability to spread
(University of California - San Diego) University of California San Diego School of Medicine researchers engineered sensors to detect and measure the metastatic potential of single cancer cells. Metastasis is attributed as the leading cause of death in people with cancer. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 5, 2018 Category: International Medicine & Public Health Source Type: news

Effect of religiosity/spirituality on ovarian cancer diagnosis in African American women
(Mary Ann Liebert, Inc./Genetic Engineering News) An examination of data from a multi-center case-control study of ovarian cancer in African American women found that women who reported higher levels of religiosity/spirituality had increased odds of stage III-IV ovarian cancer at diagnosis. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 5, 2018 Category: International Medicine & Public Health Source Type: news

Phase III KATHERINE trial crossed early reporting boundary and met its primary endpoint
(American Association for Cancer Research) Substituting trastuzumab emtansine (T-DM1, Kadcyla) for adjuvant trastuzumab (Herceptin) in patients who had residual disease after receiving neoadjuvant chemotherapy and trastuzumab reduced the risk of developing an invasive recurrence of HER2-positive early-stage breast cancer by 50 percent, according to data from the phase III clinical trial KATHERINE presented at the 2018 San Antonio Breast Cancer Symposium. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 5, 2018 Category: Cancer & Oncology Source Type: news

Adjuvant capecitabine did not improve outcomes for patients with early triple-negative breast cancer
(American Association for Cancer Research) Treating patients who had early-stage triple-negative breast cancer with the chemotherapy agent capecitabine after they completed surgery and standard chemotherapy did not significantly improve disease-free or overall survival compared with observation, according to data from the randomized, phase III GEICAM/CIBOMA clinical trial presented at the 2018 San Antonio Breast Cancer Symposium. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 5, 2018 Category: Cancer & Oncology Source Type: news

New research highlights why HIV-infected patients suffer higher rates of cancer
(Case Western Reserve University) AIDS patients suffer higher rates of cancer because they have fewer T-cells in their bodies to fight disease. But new research examines why HIV-infected patients have higher rates of cancer--among the leading causes of death among that population--than the general population. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 5, 2018 Category: Cancer & Oncology Source Type: news

Breast cancer patients who take heart drug with trastuzumab have less heart damage
(European Society of Cardiology) Breast cancer patients who take a heart drug at the same time as trastuzumab have less heart damage, according to a study presented today at EuroEcho-Imaging 2018. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 5, 2018 Category: International Medicine & Public Health Source Type: news

Anacostia community forum focuses on breast cancer
In her latest community forum, Linda Birbaum, Ph.D., visited Anacostia in southeast Washington, D.C. to meet face-to-face with community members. (read more) (Source: Environmental Factor - NIEHS Newsletter)
Source: Environmental Factor - NIEHS Newsletter - December 5, 2018 Category: Environmental Health Source Type: news